Antiosteoporotic Drugs and Incidence of Type 2 Diabetes Mellitus

ISSN： 0171-967X

Source： Calcified Tissue International, Vol.90, Iss.2, 2012-02, pp. : 163-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Type 2 Diabetes Mellitus and the Elderly: An Update on Drugs Used to Treat Glycaemia

Current Vascular Pharmacology, Vol. 15, Iss. 1, 2017-01 ,pp. : 19-29

Bentham Science Publishers

Access to resources Recommend Favorite

Incretins, insulin secretion and Type 2 diabetes mellitus

By Vilsbøll T. Holst J.

Diabetologia, Vol. 47, Iss. 3, 2004-03 ,pp. : 357-366

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Science of Type 2 Diabetes Mellitus

By Salans L.B.

Trends in Endocrinology and Metabolism, Vol. 9, Iss. 1, 1998-01 ,pp. : 43-44

Elsevier

Access to resources Recommend Favorite

Type 2 Diabetes Mellitus and Cardiovascular Exercise Performance

By Regensteiner Judith G.

Reviews in Endocrine and Metabolic Disorders, Vol. 5, Iss. 3, 2004-08 ,pp. : 269-276

Springer Publishing Company

Access to resources Recommend Favorite

Spotlight on Rosiglitazone in the Management of Type 2 Diabetes Mellitus

By Wagstaff A.J. Goa K.L.

Treatments in Endocrinology, Vol. 1, Iss. 6, 2002-01 ,pp. : 411-414

Adis International

Access to resources Recommend Favorite